17Aug
An Update on Poison Pills, NOL Poison Pills and the COVID-19 Pandemic
Since the release of our recent article “Poison Pills, NOL Poison Pills and the COVID-19 Pandemic” in midApril, we continue to see a surge in the number of companies implementing poison pills (also referred to as shareholder rights plans), a type of defensive tactic used by a corporation’s board of directors against a hostile takeover bid. Please see full Publication below for more information....
By:
Robinson & Cole LLP
Related
Pursuant to a recent Court order overturning the Trump Administration’s efforts to overturn wage an...
Read More >
The UK hydraulic fracturing industry has been in the spotlight recently as operators push for higher...
Read More >
This is the third in a trilogy of blogs discussing issues of importance for investors seeking E-2 vi...
Read More >
On September 24, 2019, the U.S. Department of Labor announced a final rule to make 1.3 million Ameri...
Read More >
Digital Health Companies Look Toward IPOs as M&A Stabilizes - Digital health funding in 2019 sugges...
Read More >
As discussed in our prior article, California recently enacted Assembly Bill (AB) 51, a law that att...
Read More >